Please enable Javascript to use all features and improve your user experience.
DMKG 2023
Programme
People
Search
DE
All people
Charly Gaul
Sort by Type
Date
Redner
01/07/2023
15:45
–
16:00
12 Min.
3 Min.
Vortrag
CGRP-Antikörper und Cluster-Kopfschmerz
Speaker
30/06/2023
19:25
–
19:30
5 Min.
0 Min.
Poster
P06
Kinetische Oszillationsstimulation zur präventiven Behandlung von chronischer Migräne
Migräne
30/06/2023
19:35
–
19:40
5 Min.
0 Min.
Poster IND
P08
Finale Ergebnisse der SPECTRE-Studie: Real-world evidence Daten zur Therapie von Migränepatienten mit Erenumab im deutschen Behandlungsalltag
Migräne
30/06/2023
19:40
–
19:45
5 Min.
0 Min.
Poster IND
P09
Effectiveness of Galcanezumab vs. Traditional Oral Migraine Preventive Medications: Interim 3-Month Results from Real-World TRIUMPH Study
Migräne
Further involvements
30/06/2023
19:00
–
19:05
5 Min.
0 Min.
Poster
P01
Beeinträchtigung durch Clusterkopfschmerz und Auswirkung auf Angehörige
Cluster
30/06/2023
19:25
–
19:30
5 Min.
0 Min.
Poster
P06
Kinetische Oszillationsstimulation zur präventiven Behandlung von chronischer Migräne
Migräne
30/06/2023
19:35
–
19:40
5 Min.
0 Min.
Poster IND
P08
Finale Ergebnisse der SPECTRE-Studie: Real-world evidence Daten zur Therapie von Migränepatienten mit Erenumab im deutschen Behandlungsalltag
Migräne
30/06/2023
19:40
–
19:45
5 Min.
0 Min.
Poster IND
P09
Effectiveness of Galcanezumab vs. Traditional Oral Migraine Preventive Medications: Interim 3-Month Results from Real-World TRIUMPH Study
Migräne
30/06/2023
19:45
–
19:50
5 Min.
0 Min.
Poster IND
P10
Fremanezumab Effectiveness and Tolerability in Clinical Routine: Interim Real-World-Data of the Observational FINESSE Study
Migräne
30/06/2023
19:50
–
19:55
5 Min.
0 Min.
Poster IND
P11
Early onset of Real-World Effectiveness of Fremanezumab in Patients with Migraine who switched from another mAb targeting the CGRP pathway (subgroup analysis from FINESSE)
Migräne
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy